USE OF HDACI AND PD-1/PD-LI BLOCKADE TO ENHANCE CYTOLYTIC ACTIVITY OF EX VIVO EXPANDED NK CELLS AGAINST NEUROBLASTOMA

被引:0
|
作者
Shen, S. [1 ,2 ,3 ]
Dolnikov, A. [1 ,2 ,3 ]
O'Brien, T. [1 ,2 ,3 ]
机构
[1] Sydney Childrens Hosp, Kids Canc Ctr, Randwick, NSW, Australia
[2] Univ New S Wales, Fac Med, Sydney, NSW, Australia
[3] Childrens Canc Inst Med Res, Sydney, NSW, Australia
关键词
D O I
暂无
中图分类号
Q813 [细胞工程];
学科分类号
摘要
185
引用
收藏
页码:S64 / S64
页数:1
相关论文
共 50 条
  • [41] HIV-1-Specific CAR-T Cells With Cell-Intrinsic PD-1 Checkpoint Blockade Enhance Anti-HIV Efficacy in vivo
    Jiang, Zhengtao
    Liang, Huitong
    Pan, Hanyu
    Liang, Yue
    Wang, Hua
    Yang, Xinyi
    Lu, Panpan
    Zhang, Xiao
    Yang, Jinlong
    Zhang, Dengji
    Shen, Xiaoting
    Wang, Jing
    Liang, Zhiming
    Lin, Qinru
    Wang, Yanan
    Zhao, Lin
    Zhong, Yangcheng
    Lu, Hongzhou
    Zhu, Huanzhang
    FRONTIERS IN MICROBIOLOGY, 2021, 12
  • [42] PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells
    Balanca, Camille-Charlotte
    Salvioni, Anna
    Scarlata, Clara-Maria
    Michelas, Marie
    Martinez-Gomez, Carlos
    Gomez-Roca, Carlos
    Sarradin, Victor
    Tosolini, Marie
    Valle, Carine
    Pont, Frederic
    Ferron, Gwenael
    Gladieff, Laurence
    Vergez, Sebastien
    Dupret-Bories, Agnes
    Mery, Eliane
    Rochaix, Philippe
    Fournie, Jean-Jacques
    Delord, Jean-Pierre
    Devaud, Christel
    Martinez, Alejandra
    Ayyoub, Maha
    JCI INSIGHT, 2021, 6 (02)
  • [43] PD-1 Blockade by CT-011, Anti-PD-1 Antibody, Enhances Ex Vivo T-cell Responses to Autologous Dendritic Cell/Myeloma Fusion Vaccine
    Rosenblatt, Jacalyn
    Glotzbecker, Brett
    Mills, Heidi
    Vasir, Baldev
    Tzachanis, Dimitrios
    Levine, James D.
    Joyce, Robin M.
    Wellenstein, Kerry
    Keefe, Whitney
    Schickler, Michael
    Rotem-Yehudar, Rinat
    Kufe, Donald
    Avigan, David
    JOURNAL OF IMMUNOTHERAPY, 2011, 34 (05) : 409 - 418
  • [44] Ex vivo Hsp70-Activated NK Cells in Combination With PD-1 Inhibition Significantly Increase Overall Survival in Preclinical Models of Glioblastoma and Lung Cancer
    Shevtsov, Maxim
    Pitkin, Emil
    Ischenko, Alexander
    Stangl, Stefan
    Khachatryan, William
    Galibin, Oleg
    Edmond, Stanley
    Lobinger, Dominik
    Multhoff, Gabriele
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [45] Coactivation of innate immune suppressive cells induces acquired resistance against combined TLR agonism and PD-1 blockade
    Nishinakamura, Hitomi
    Shinya, Sayoko
    Irie, Takuma
    Sakihama, Shugo
    Naito, Takeo
    Watanabe, Keisuke
    Sugiyama, Daisuke
    Tamiya, Motohiro
    Yoshida, Tatsuya
    Hase, Tetsunari
    Yoshida, Takao
    Karube, Kennosuke
    Koyama, Shohei
    Nishikawa, Hiroyoshi
    SCIENCE TRANSLATIONAL MEDICINE, 2025, 17 (785)
  • [46] Bacteria Synergized with PD-1 Blockade Enhance Positive Feedback Loop of Cancer Cells-M1 Macrophages-T Cells in Glioma
    Chen, Qi
    Zheng, Yuyi
    Chen, Xiaojie
    Xing, Yuan
    Zhang, Jiajie
    Yan, Xinyi
    Zhang, Qi
    Wu, Di
    Chen, Zhong
    ADVANCED SCIENCE, 2024, 11 (20)
  • [47] Site-Selective Functionalized PD-1 Mutant for a Modular Immunological Activity against Cancer Cells
    Fallarini, Silvia
    Cerofolini, Linda
    Salobehaj, Maria
    Rizzo, Domenico
    Gheorghita, Giulia Roxana
    Licciardi, Giulia
    Capialbi, Daniela Eloisa
    Zullo, Valerio
    Sodini, Andrea
    Nativi, Cristina
    Fragai, Marco
    BIOMACROMOLECULES, 2023, 24 (11) : 5428 - 5437
  • [48] Epigenetic modulation combined with PD-1/PD-L1 blockade enhance immunotherapy based on MAGE-A11 antigen specific CD8+T cells
    Wu, Y.
    Sang, M.
    Shan, B.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1810 - 1810
  • [49] Ex vivo single cell RNA sequencing of tumor derived organotypic spheroids identifies a unique mesenchymal resistance program to PD-1 blockade
    Portell, Andrew J.
    Greene, Jonathan
    Taus, Luke J.
    Lizotte, Patrick
    Ivanova, Elena
    Menezes, Kalil O.
    Aref, Amir R.
    Kirschmeier, Paul
    Jenkins, Russell W.
    Barbie, David
    Paweletz, Cloud P.
    CANCER RESEARCH, 2019, 79 (13)
  • [50] Ex vivo expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells through different receptor-ligand interactions
    Daun Jung
    Young Seok Baek
    In Jee Lee
    Ki Yeon Kim
    Heejoo Jang
    Sohyun Hwang
    Jieun Jung
    Yong-wha Moon
    Kyung-Soon Park
    Yong-Soo Choi
    Hee Jung An
    Journal of Experimental & Clinical Cancer Research, 40